Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used.
Dr. Tiziano Barbui
Advertisement
Barbui is a professor of hematology and founder of the department of hematology at Bergamo Hospital. He is currently the scientific director of clinical research foundation at Papa Giovanni XXIII Hospital, Bergamo, Italy.
Articles by Dr. Tiziano Barbui
Arterial thrombosis may occur years before cancer diagnosis, suggesting it could be a risk factor, according to Dr. Tiziano Barbui.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer
2
FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC
3
Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer
4
A Stranger Who Became a Friend
5
